Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Br J Cancer ; 98(8): 1403-14, 2008 Apr 22.
Article in English | MEDLINE | ID: mdl-18382428

ABSTRACT

Robust protocols for microarray gene expression profiling of archival formalin-fixed paraffin-embedded tissue (FFPET) are needed to facilitate research when availability of fresh-frozen tissue is limited. Recent reports attest to the feasibility of this approach, but the clinical value of these data is poorly understood. We employed state-of-the-art RNA extraction and Affymetrix microarray technology to examine 34 archival FFPET primary extremity soft tissue sarcomas. Nineteen arrays met stringent QC criteria and were used to model prognostic signatures for metastatic recurrence. Arrays from two paired frozen and FFPET samples were compared: although FFPET sensitivity was low ( approximately 50%), high specificity (95%) and positive predictive value (92%) suggest that transcript detection is reliable. Good agreement between arrays and real time (RT)-PCR was confirmed, especially for abundant transcripts, and RT-PCR validated the regulation pattern for 19 of 24 candidate genes (overall R(2)=0.4662). RT-PCR and immunohistochemistry on independent cases validated prognostic significance for several genes including RECQL4, FRRS1, CFH and MET - whose combined expression carried greater prognostic value than tumour grade - and cmet and TRKB proteins. These molecules warrant further evaluation in larger series. Reliable clinically relevant data can be obtained from archival FFPET, but protocol amendments are needed to improve the sensitivity and broad application of this approach.


Subject(s)
Gene Expression Profiling , Neoplasms/metabolism , Oligonucleotide Array Sequence Analysis , Biomarkers, Tumor/genetics , Formaldehyde , Humans , Neoplasms/pathology , Paraffin Embedding , Prognosis , Reverse Transcriptase Polymerase Chain Reaction , Tissue Fixation
2.
Br J Radiol ; 79(944): e40-4, 2006 Aug.
Article in English | MEDLINE | ID: mdl-16861316

ABSTRACT

Imatinib is a highly effective treatment for patients with metastatic gastrointestinal stromal tumours (GIST). In most instances, response to imatinib treatment is assessed with CT. We present two cases where CT demonstrated the appearance of new low density liver lesions after 8-12 weeks of imatinib treatment. While this finding is consistent with progressive disease due to new lesions appearing at a previously uninvolved site, we hypothesise that the appearance of new liver lesions is in fact due to cystic change within previously occult, solid metastases. These untreated solid metastases were not visible on conventional portal phase CT due to their small size and vascular nature. Our hypothesis is supported by the observation that extrahepatic sites of disease had reduced in size over the same period of imatinib treatment and by the subsequent disease outcomes of these two cases. One patient, who continued imatinib because of significant symptomatic improvement despite the CT findings, remained stable on the same dose of imatinib for 18 months. The other patient, whose disease progressed when imatinib was withdrawn, had a dramatic response to treatment when imatinib was restarted at the same dose 2 years later. It is important that radiologists and oncologists who are involved in the management of GIST recognize that the appearance of new, low-density liver lesions on CT may represent a response to treatment. This finding must be correlated with symptomatic response and with tumour sites outside the liver before erroneously withdrawing effective imatinib treatment.


Subject(s)
Antineoplastic Agents/therapeutic use , Cysts/diagnostic imaging , Gastrointestinal Stromal Tumors/drug therapy , Liver Neoplasms/secondary , Piperazines/therapeutic use , Pyrimidines/therapeutic use , Aged , Benzamides , Diagnostic Errors , Disease Progression , Female , Humans , Imatinib Mesylate , Liver Neoplasms/diagnostic imaging , Liver Neoplasms/drug therapy , Male , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...